India's pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 ...

RA: What do you think the implications would be of restrictions to the FDI policy in pharma? TR: India witnessed the second highest growth ... industry, in the globalized economy. 2) Need for ...

Commerce and Industry Minister Piyush Goyal highlighted the importance of innovation for the growth of India's pharmaceutical ...

Strong pricing growth (+5.3 per cent YoY) and the launch of new products from recent patent expiries (+2.6 per cent YoY ... selling English daily in North India, publishes news and views without ...

As India’s pharmaceutical and healthcare industries ... An increase in healthcare spending to 2.5-3% of GDP is necessary for sustained industry growth. With a strategic policy push, India is ...

increased demand for pharmaceutical products and a revival in export activities. Sheetal Sapale, vice-president (commercial), Pharmarack, said, "The growth is pretty much in line with the India ...

India’s pharmaceutical industry stands at a pivotal moment. By prioritising quality as a driver of competitive advantage, the sector can sustain its growth trajectory, address global challenges ...

the industry now looks forward to policies that further align with India’s ambition of becoming a $130B pharma market by 2030. “This year’s expectations revolve around incentivising research ...

The Indian pharma market, currently valued at around USD 55 billion, is projected to expand 2.2 to 2.4 times over the next ...